ABATACEPT CONFERS CLINICAL EFFICACY REGARDLESS OF BASELINE CRP STATUS IN PATIENTS WITH RHEUMATOID ARTHRITIS AND INADEQUATE RESPONSE TO METHOTREXATE IN THE AIM TRIAL

被引：0

作者：

Sibilia, Jean ^{[1
]}

Flipo, Rene Marc ^{[2
]}

Combe, Bernard ^{[3
]}

Gaillez, Corine ^{[4
]}

Le Bars, Manuela ^{[4
]}

Poncet, Coralie ^{[5
]}

Elegbe, Ayanbola ^{[6
]}

Westhovens, Rene ^{[7
]}

机构：

[1] Univ Strasbourg, Dept Rheumatol, Strasbourg, France

[2] Ctr Hosp Univ France, Dept Rheumatol, Lille, France

[3] Hop Lapeyronie, Montpellier, France

[4] Bristol Myers Squibb Co, Med Affairs, Rueil Malmaison, France

[5] Docs Int, Dept Biostat, Sevres, France

[6] Bristol Myers Squibb Co, Global Biometr Sci, Princeton, NJ USA

[7] Univ Hosp Gasthuisberg, Dept Rheumatol, Louvain, Belgium

来源：

RHEUMATOLOGY | 2012年 / 51卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：124 / 125

页数：2

共 50 条

[21] Cost-effectiveness of abatacept in patients with moderately to severely active rheumatoid arthritis and inadequate response to methotrexate [J].

Vera-Llonch, M. ;

Massarotti, E. ;

Wolfe, F. ;

Shadick, N. ;

Westhovens, R. ;

Sofrygin, O. ;

Maclean, R. ;

Yuan, Y. ;

Oster, G. .

RHEUMATOLOGY, 2008, 47 (04) :535-541

[22] In abatacept-treated rheumatoid arthritis patients, rapid and significant improvements were observed in the components of the ACR criteria for the phase III aim (abatacept in inadequate responders to methotrexate) trial [J].

Abud-Mendoza, C ;

Steinfeld, S ;

Aranda, R ;

Becker, JC ;

Kremer, J ;

Thorne, C ;

Teng, J .

JOURNAL OF RHEUMATOLOGY, 2006, 33 (02) :392-392

[23] Longterm Safety, Efficacy, and Inhibition of Structural Damage Progression Over 5 Years of Treatment with Abatacept in Patients with Rheumatoid Arthritis in the Abatacept in Inadequate Responders to Methotrexate Trial [J].

Kremer, Joel M. ;

Peterfy, Charles ;

Russell, Anthony S. ;

Emery, Paul ;

Abud-Mendoza, Carlos ;

Sibilia, Jean ;

Becker, Jean-Claude ;

Westhovens, Rene ;

Genant, Harry K. .

JOURNAL OF RHEUMATOLOGY, 2014, 41 (06) :1077-1087

[24] Long-term safety and efficacy of abatacept in patients with rheumatoid arthritis and an inadequate response to methotrexate: a 7-year extended study [J].

Westhovens, R. ;

Kremer, J. M. ;

Emery, P. ;

Russell, A. S. ;

Alten, R. ;

Barre, E. ;

Dougados, M. .

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2014, 32 (04) :553-562

[25] Impact of intravenous abatacept on synovitis, osteitis and structural damage in patients with rheumatoid arthritis and an inadequate response to methotrexate: the ASSET randomised controlled trial [J].

Conaghan, Philip G. ;

Durez, Patrick ;

Alten, Rieke E. ;

Burmester, Gerd-Ruediger ;

Tak, Paul P. ;

Klareskog, Lars ;

Catrina, Anca Irinel ;

DiCarlo, Julie ;

Gaillez, Corine ;

Le Bars, Manuela ;

Zhou, Xianhuang ;

Peterfy, Charles .

ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 (08) :1287-1294

[26] Phase II dose-response study of abatacept in Japanese patients with active rheumatoid arthritis with an inadequate response to methotrexate [J].

Takeuchi, Tsutomu ;

Matsubara, Tsukasa ;

Nitobe, Taisuke ;

Suematsu, Eiichi ;

Ohta, Syuji ;

Honjo, Shigeru ;

Abe, Tohru ;

Yamamoto, Ami ;

Miyasaka, Nobuyuki .

MODERN RHEUMATOLOGY, 2013, 23 (02) :226-235

[27] Clinical efficacy and safety of etanercept plus methotrexate or etanercept alone in rheumatoid arthritis patients with inadequate response to methotrexate: The ADORE study [J].

Taggart, A. J. ;

van Riel, P. L. C. M. ;

Reynolds, A. ;

Sany, J. ;

Gaubitz, M. ;

Phillips, C. ;

Pedersen, R. ;

Singh, A. ;

MacPeek, D. .

RHEUMATOLOGY, 2006, 45 :I45-I45

[28] Efficacy and safety of filgotinib in patients with moderately active rheumatoid arthritis and an inadequate response to methotrexate [J].

Buch, Maya H. ;

Walker, David ;

Edwards, Christopher J. ;

Barry, Jane ;

Akroyd, Laura ;

Omoruyi, Edmund V. Ekoka ;

Taylor, Peter C. .

RHEUMATOLOGY, 2024, :1661-1671

[29] Efficacy and Safety of Certolizumab Pegol Plus Methotrexate in Japanese Rheumatoid Arthritis Patients with An Inadequate Response to Methotrexate [J].

Yamamoto, Kazuhiko ;

Takeuchi, Tsutomu ;

Yamanaka, Hisashi ;

Ishiguro, Naoki ;

Tanaka, Yoshiya ;

Eguchi, Katsumi ;

Watanabe, Akira ;

Origasa, Hideki ;

Shoji, Toshiharu ;

Sakamaki, Yoshiharu ;

Miyasaka, Nobuyuki ;

Koike, Takao .

ARTHRITIS AND RHEUMATISM, 2011, 63 (10) :S474-S475

[30] Cost-effectiveness of abatacept in patients with moderately to severely active rheumatoid arthritis and inadequate response to methotrexate in Brazil [J].

Alves, M. R. ;

Carvalho, F., Jr. ;

Litalien, G. .

VALUE IN HEALTH, 2008, 11 (03) :A260-A260

← 1 2 3 4 5 →